SEC Comment Letter 0000000000-23-010584 to iHuman Inc. (IH)
iHuman Inc.
Date: Sept. 26, 2023 · CIK: 0001814423 · Accession: 0000000000-23-010584
AI Filing Summary & Sentiment
File numbers found in text: 001-39591
Referenced dates: August 31, 2023
Show Raw Text
United States securities and exchange commission logo
September 26, 2023
Vivien Weiwei Wang
Chief Financial Officer
iHuman Inc.
Floor 8, Building B
No. 1 Wangjing East Road
Chaoyang District, Beijing 100102
People’s Republic of China
Re:iHuman Inc.
Form 20-F for Fiscal Year Ended December 31, 2022
Response dated August 31, 2023
File No. 001-39591
Dear Vivien Weiwei Wang:
We have reviewed your August 31, 2023 response to our comment letter and have the
following comments. In some of our comments, we may ask you to provide us with information
so we may better understand your disclosure.
Please respond to these comments within ten business days by providing the requested
information or advise us as soon as possible when you will respond. If you do not believe our
comments apply to your facts and circumstances, please tell us why in your response.
After reviewing your response to these comments, we may have additional
comments. Unless we note otherwise, our references to prior comments are to comments in our
August 3, 2023 letter.
Response Letter dated August 31, 2023
"Our business generates and processes data in the ordinary course, and we are required to
comply with PRC and . . . ", page 23
1.We note your response to comment 9, as well as your proposed disclosure that "[a]s
advised by our PRC counsel, as of the date of this annual report, we are in compliance
with the existing PRC laws and regulations on cybersecurity, data security and personal
data protection issued by the CAC in material aspects.” The disclosure here should not be
qualified by materiality. Please make appropriate revisions and tell us what your
disclosure will look like.
FirstName LastNameVivien Weiwei Wang
Comapany NameiHuman Inc.
September 26, 2023 Page 2
FirstName LastName
Vivien Weiwei Wang
iHuman Inc.
September 26, 2023
Page 2
General
2.We note the additional changes, beyond those sought by our August 3, 2023 comment
letter, that you have made to your proposed revised disclosure to appear in future annual
report filings, especially changes in the "Item 3. Key Information" and "Risk
Factors" sections relating to legal and operational risks associated with operating in China
and PRC regulations. It is unclear to us that there have been changes in the regulatory
environment in the PRC since your annual report on Form 20-F was filed on April 25,
2023, warranting revised disclosure to mitigate the challenges you face and related
disclosures. The Sample Letters to China-Based Companies sought specific disclosure
relating to the risk that the PRC government may intervene in or influence your operations
at any time, or may exert control over operations of your business, which could result in a
material change in your operations and/or the value of your ADSs. We remind you that,
pursuant to federal securities rules, the term “control” (including the terms “controlling,”
“controlled by,” and “under common control with”) as defined in Securities Act Rule 405
means “the possession, direct or indirect, of the power to direct or cause the direction of
the management and policies of a person, whether through the ownership of voting
securities, by contract, or otherwise.” The Sample Letters also sought specific disclosures
relating to uncertainties regarding the enforcement of laws and that the rules and
regulations in China can change quickly with little advance notice, as well as the risks if
the PRC government determines that the contractual arrangements constituting part of the
VIE structure do not comply with PRC regulations, or if these regulations change or are
interpreted differently in the future. We do not believe that your proposed disclosure that
removes detailed references to the PRC legal system and the nature of the PRC
government’s regulatory oversight conveys the same risks. In future annual reports,
please restore your disclosures in these areas to the disclosures as they existed in the
annual report on Form 20-F filed April 25, 2023, as modified by your responses to our
August 3, 2023 comment letter, and otherwise updated, as necessary, to reflect then
existing facts and circumstances. Please show us what your disclosure will look like,
assuming you were to file an annual report on the date of your response to this comment..
Please contact Brian Fetterolf at 202-551-6613 or Dieter King at 202-551-8071 with any
questions.
Sincerely,
Division of Corporation Finance
Office of Trade & Services